Literature DB >> 17869049

Impact of methadone on drug use and risky sex in China.

Han-Zhu Qian1, Chun Hao, Yuhua Ruan, Holly M Cassell, Kanglin Chen, Guangming Qin, Lu Yin, Joseph E Schumacher, Shu Liang, Yiming Shao.   

Abstract

This study examined the impact of methadone on drug-using and risky sexual behaviors among 557 heroin injection drug users in one of the first methadone programs in China. Structured questionnaires were administered to collect data on methadone utilization, drug use, and risky sexual behaviors. Blood samples were tested for blood-borne infections. Multivariate logistic analyses revealed that, among opioid-addicted individuals, methadone participants were less likely to use or inject drugs and share needles than nonparticipants. They also were less likely to have multiple sexual partners or have unprotected sex. Those currently enrolled in methadone maintenance had lower risk of using and injecting drugs than those who were no longer receiving methadone. Data suggest positive, short-term impact on these important behaviors, but further studies are needed to examine the long-term impact of methadone treatment on disease rates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17869049     DOI: 10.1016/j.jsat.2007.07.002

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  19 in total

Review 1.  Drug treatment as HIV prevention: a research update.

Authors:  David S Metzger; George E Woody; Charles P O'Brien
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

2.  HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial.

Authors:  George E Woody; Douglas Bruce; P Todd Korthuis; Sumedha Chhatre; Sabrina Poole; Maureen Hillhouse; Petra Jacobs; James Sorensen; Andrew J Saxon; David Metzger; Walter Ling
Journal:  J Acquir Immune Defic Syndr       Date:  2014-07-01       Impact factor: 3.731

3.  The Chinese government's response to drug use and HIV/AIDS: a review of policies and programs.

Authors:  Jianhua Li; Toan H Ha; Cunmin Zhang; Hongjie Liu
Journal:  Harm Reduct J       Date:  2010-03-05

4.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.

Authors:  David S Metzger; Deborah Donnell; David D Celentano; J Brooks Jackson; Yiming Shao; Apinun Aramrattana; Liu Wei; Liping Fu; Jun Ma; Gregory M Lucas; Marek Chawarski; Yuhua Ruan; Paul Richardson; Katherine Shin; Ray Y Chen; Jeremy Sugarman; Bonnie J Dye; Scott M Rose; Geetha Beauchamp; David N Burns
Journal:  J Acquir Immune Defic Syndr       Date:  2015-04-15       Impact factor: 3.731

Review 5.  Drug treatment as HIV prevention: expanding treatment options.

Authors:  David S Metzger; Yan Zhang
Journal:  Curr HIV/AIDS Rep       Date:  2010-11       Impact factor: 5.071

6.  HIV seroconversion and risk factors among drug users receiving methadone maintenance treatment in China: A qualitative study.

Authors:  Changhe Wang; Cynthia X Shi; Bo Zhang; Hong Chen; Hua Wang; Nanci Zhang; Keming Rou; Xiaobin Cao; Wei Luo; Zunyou Wu
Journal:  Drug Alcohol Depend       Date:  2016-08-21       Impact factor: 4.492

7.  Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings.

Authors:  R Douglas Bruce
Journal:  Int J Drug Policy       Date:  2010-03

8.  The Impact of Methadone Maintenance Treatment on HIV Risk Behaviors among High-Risk Injection Drug Users: A Systematic Review.

Authors:  Pramila Karki; Roman Shrestha; Tania B Huedo-Medina; Michael Copenhaver
Journal:  Evid Based Med Public Health       Date:  2016-03-22

Review 9.  The effectiveness of compulsory drug treatment: A systematic review.

Authors:  D Werb; A Kamarulzaman; M C Meacham; C Rafful; B Fischer; S A Strathdee; E Wood
Journal:  Int J Drug Policy       Date:  2015-12-18

10.  Effectiveness of integrated HIV prevention interventions among Chinese men who have sex with men: evaluation of a 16-city public health program.

Authors:  Shaodong Ye; Yan Xiao; Canrui Jin; Holly Cassell; Meridith Blevins; Jiangping Sun; Sten H Vermund; Han-Zhu Qian
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.